気管・気管支ステントの世界市場：規模、シェア、COVID-19の影響分析（2023年～2029年）：MedCore

世界の気管・気管支ステントの市場規模は、2022年に2億1,630万米ドルとなりました。同市場は予測期間中に-2.2%のCAGRで減少し、1億8,570万米ドルになると予測されています。

当レポートでは、世界の気管・気管支ステント市場について調査し、市場の概要とともに、セグメント別、地域別動向、競合情勢などを提供しています。

目次

気管・気管支ステント市場

• イントロダクション
• 市場概要
• 市場分析と予測
  • 気管・気管支ステント市場
  • 気管・気管支メタルステント市場
  • 気管・気管支シリコーンステント市場
• 促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 競合市場シェア分析

LIST OF CHARTS

• Chart 17-1: Tracheobronchial Stent Market by Segment, U.S., 2019 - 2029
• Chart 17-2: Leading Competitors, Tracheobronchial Stent Market, U.S., 2022

LIST OF FIGURES

• Figure 17-1: Tracheobronchial Stent Market by Segment, U.S., 2019 - 2029 (US$M)
• Figure 17-2: Tracheobronchial Stent Market, U.S., 2019 - 2029
• Figure 17-3: Metal Tracheobronchial Stent Market, U.S., 2019 - 2029
• Figure 17-4: Silicone Tracheobronchial Stent Market, U.S., 2019 - 2029
• Figure 17-5: Leading Competitors, Tracheobronchial Stent Market, U.S., 2022

The global market for tracheobronchial stents was valued at $216.3 million in 2022, with an anticipated decrease over the forecast period at a CAGR of -2.2%, ultimately reaching $185.7 million. The market report covers both metal and silicone tracheobronchial stents.

MARKET DATA INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends

• Procedure Numbers

• COVID-19 Impact Analysis

• Market Drivers & Limiters

• Market Forecasts Until 2029, and Historical Data to 2019

• Recent Mergers & Acquisitions

• Company Profiles and Product Portfolios

• Leading Competitors

GLOBAL TRACHEOBRONCHIAL STENT MARKET INSIGHTS

A significant factor driving the market growth is the preference for silicone stents over their metal counterparts. Unlike metal stents, which are permanently implanted in a patient's airways, silicone stents can be removed or replaced to mitigate potential complications for the patient.

GLOBAL TRACHEOBRONCHIAL STENT MARKET SHARE INSIGHTS

The Global tracheobronchial market was led by Getinge, Boston Scientific, and Merit Medical.

Getinge was the top player in the tracheobronchial stent industry, operating exclusively in the metal tracheobronchial stent category with its iCAST™ Balloon Expandable Covered Stent. However, it's worth mentioning that a significant portion of the product sales may be utilized off-label for peripheral vascular interventions such as iliac, for which the international variant of the stent, Advanta™ V12, has CE and regional clearance.

MARKET SEGMENTATION SUMMARY

Tracheobronchial Stent Market - MedCore - Includes:

• Metal and silicone tracheobronchial stents.

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

• Base Year: 2022
• Forecast Period: 2023-2029
• Historical Data: 2019-2022

• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices

• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios

• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

WHY CHOOSE IDATA?

• Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

• Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

• Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

• Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

Table of Contents

Tracheobronchial Stent Market

• 17.1 Introduction
• 17.2 Market Overview
• 17.3 Market Analysis and Forecast
  • 17.3.1 Tracheobronchial Stent Market
  • 17.3.2 Metal Tracheobronchial Stent Market
  • 17.3.3 Silicone Tracheobronchial Stent Market
• 17.4 Drivers and Limiters
  • 17.4.1 Market Drivers
  • 17.4.2 Market Limiters
• 17.5 Competitive Market Share Analysis